chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Aching in joints; This is a spontaneous report received from a contactable consumer. This consumer (parent) reported for 16 years old male patient that received second dose of bnt162b2 (BNT162B2, Pfizer COVID 19), via an unspecified route of administration, administered in Arm Left on 12Apr2021 15:30 (Lot Number: EP6955) as single dose for covid-19 immunisation. Medical history included attention deficit hyperactivity disorder (ADHD) from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient previously took first dose of bnt162b2 (BNT162B2, Pfizer COVID 19, Lot Number: EP6955) on 22Mar2021 at 03:30 AM in Arm Left for covid-19 immunisation. The patient experienced aching in joints, continuing for 18 hours on 12Apr2021 18:00 with outcome of recovered. Therapeutic measures were taken as a result of aching in joints included Tylenol and Advil. No covid prior vaccination. No covid tested post vaccination. Known allergies was none. Facility where the most recent COVID-19 vaccine was administered was workplace clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No other medications the patient received within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.   No follow-up attempts are needed. No further information is expected.
35-year-old female with history of asthma presents for evaluation of allergic reaction. Patient says she has a history of allergy to the flu shot.  She received the first Covid 19 vaccination following her visit with her pulmonology provider today. Shortly after this she developed feelings of throat closure, wheezing and a hoarseness to her voice. She was brought down to the emergency department for further evaluation. She has no history of anaphylaxis and has never been given the EpiPen. She denies any history of chest pain, abdominal pain, nausea/vomiting, skin rash, lightheadedness or dizziness.    Medications Given in the ED:    4/02 Meds   1:24 p Famotidine 20 mg IV Push; MethylPREDNISolone 125 mg IV Push; DiphenhydrAMINE 25 mg IV Push  1:21 p Albuterol-ipratropium 3 mL Aerosolized 35-year-old female presents for evaluation of allergic reaction following Covid 19 vaccination. Overall she is in no acute respiratory distress. Initially when I walked into the room she did appear anxious, and her voice was a bit hoarse. Lung sounds show subtle wheezing bilaterally. Respiratory at bedside. On further conversation with the patient her voice clarity seemed to improve significantly and she seems to be talking at her baseline. She feels overall that the sensation of throat closure is improving. No other symptoms to suggest acute anaphylaxis and we'll hold on epinephrine administration at this time. Patient was administered IV Benadryl, famotidine, Solu-Medrol in the emergency department.  She was observed for approximately 2 hours after which time she says she is feeling back to baseline. We'll plan to discharge with prescription for EpiPen, and instructions for use discussed with the patient. Also discharged with prescription for burst course prednisone steroids. Return precautions discussed and she was discharged in stable condition.
Extreme pain and swelling in arm down to finger tips, lack of blood flow. Hands and fingers were turning white, rings had to be removed from swelling.  Swelling  and pain for 3 days.  Also, Eye sight was blurry the day of injection  and still persisting now on day 8.  Hard to focus on reading materials up close. No prior vision problems prior to injection
10/18/2022, in the evening, I have been told I had a Metabolic Seizure, hours after dose 3 of my vaccine. I was taken to the hospital on 10/20/22, on my birthday. I woke up 3-4 days later. I was in the hospital ten days.
. I had minor reactions to first two doses of Pfizer in March/April 2021  besides sore arm-and odd arm feeling .   Day 1: Wednesday About 1pm get injection hurts immediately but arm isn?t super sore. Do my ?15 min timeout at Pharmacy? Felt nothing while waiting then walked to car and suddenly felt tingling across top of bottom of my feet.   I went right back in and told pharmacists and one starts talking to me saying she had happen and took two months to go away hers was painful and feet would buckle. She?s asking if I had water I had brought but forgotten to drink so I down the bottle and it stops. I  eat a little granola bar and drive 45 min home praying no more side effects while downing another bottle of water.  3pm-1am I?m feeling normal cleaning and going on then start to feel really tired and left side of body shot side - feels weird -as it did with my very first shot not painful just like aware of it.  Day 2. I tossed and turned all night at some point like 5am my arm was hurting so bad I couldn?t even lay on that side -take pain medicine and keep tossing and turning. I?m super exhausted. Brain kinda slow take cold medicine get spurts of energy then feel crappy. Night time my glands under shot arm swell not visible but painful to move arm because pressing lymph node and I have swollen boils behind one ear and a small skin rash on right hand. Take Benadryl.  Day 3 slept for 9 hours feel the worst back hurts right side of head hurts - lymph nodes under arm still swollen. I can?t hardly move talk feed myself change clothes need help doing everything. Super slow - like staring at my hand and napkin slow - I?m hot and cold off and on not severe chills but annoying. Don?t wanna move. Take couple doses of cold Medicine, pain pill and Benadryl throughout day and eat and now at 9/10pm starting to feel more normal.   Days 4 & 5 feel I am beginning to be back to normal then tingling begins again in big toes eventually to entire bottom of feet. Various aches and pains begin moving around fingers, arms, legs, toes and sometimes head and chest. December 3 rd horrible arm aching pain cannot sleep without 600 ibuprofen  tingling and random aches. Meet with neurologist Dec 3 video visit. Doctor asked me to come to office for neurological exam I did on Dec. 15. Dec 1 st - Dec 5/6th feeling ?off? right side of  head like perhaps I?m going to lose balance or faint. Eventually improves. Still have floating aches that last for usually under one minute and tingling feet intermittently. Also a strange feeling on left side. I also had this with my first two Pfizer vaccines but it did not last as long - like an awareness of left arm and leg a strange feeling can?t be explained.   Symptoms have improved but not disappeared. Heavy tingling in bottoms of feet tonight.
After 2nd Rotateq -> 6 days of intermittent fussiness with apparent abdominal pain lasting about 1 hour-6-10 x in 24 hrs-no fever-no V&D-nl BM's with foul odor-appetite normal-difficulty to console during episodes- "fine" before and after episodes
Presents with c/o feeling weak, thought her throat was closing up and had difficulty breathing. 5 hours after ZOSTAVAX vaccine given. Given BENADRYL and transported to hospital for IVF, IVP steroids and discharged home.
4/19/2021 5:30pm: headache 7:30pm: severe headache over right eye. nausea 9:30pm: severe headache over right eye, nausea, vomiting, muscle aches, chills 3:00am: all symptoms as above with a 101.7 fever (took 2 motrin) 8:00am: all symptoms to a mimimum. continued motrin every 4-6 hours.  4/20/2021 headache and nausea came in waves all day with body aches - motrin throughout the day  4/21/2021 headache/ nausea came in waves - motrin twice  4/22/2021 nausea/headache in the morning - motrin once  4/23/2021 no symptoms
This case was reported by a physician via call center representative and described the occurrence of dizziness in a adult female patient who received BOOSTRIX. Co-suspect products included RABAVERT. Concomitant products included CYMBALTA. On 3rd November 2015, the patient received BOOSTRIX and RABAVERT. on 4th November 2015, 1 days after receiving BOOSTRIC and RABAVERT, the patient experienced dizziness and throat swelling. The patient was treated with prednisone and antihistamine. On an unknown date, the outcome of the dizziness and throat swelling were unknown. The reporter considered the dizziness and throat swelling to be possibly related to BOOSTRIX and RABAVERT. Additional details were received as follows: On 3rd November 2015, in the evening, the patient received a dose of BOOSTRIX and RABAVERT. On 4th November 2015, in the morning the patient experienced dizziness and swollen throat.
Pt has a golf ball size swelling at site of injection. Slight pain and radiates heat
received 3 doses of the Pfizer vaccine; tested positive for Covid; tested positive for Covid; O2 level had decreased to 93%; my pulse rate was 95; difficulty breathing; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP) for a Pfizer sponsored program. The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single, (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "autoimmune disease" (unspecified if ongoing), notes: taking immunosuppressive medication. The patient's concomitant medications were not reported. The following information was reported: IMMUNISATION (medically significant), outcome "unknown", described as "received 3 doses of the Pfizer vaccine"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 12Jan2022, outcome "unknown" and all described as "tested positive for Covid"; OXYGEN SATURATION DECREASED (non-serious) with onset 12Jan2022, outcome "recovered" (13Jan2022), described as "O2 level had decreased to 93%"; HEART RATE INCREASED (non-serious) with onset 12Jan2022, outcome "recovered" (13Jan2022), described as "my pulse rate was 95"; DYSPNOEA (non-serious) with onset 12Jan2022, outcome "unknown", described as "difficulty breathing". The patient underwent the following laboratory tests and procedures: heart rate: (12Jan2022) 95; (13Jan2022) 62 bpm; oxygen saturation decreased: (12Jan2022) 93 %, notes: decreased; (13Jan2022) 99 %, notes: increased; sars-cov-2 test: (12Jan2022) positive. Therapeutic measures were taken as a result of oxygen saturation decreased; heart rate increased.  Clinical course: Patient was at high risk of developing severe illness for COVID-19 due to an autoimmune disease and taking immunosuppressive medication. Patient had received 3 doses of the Pfizer vaccine but unfortunately tested positive for Covid on 12Jan2022. Within 24 hours, Patient O2 level had decreased to 93%, pulse rate was 95 and patient was having difficulty breathing. Patient was selected and approved to receive Paxlovid on 13Jan2022. He had taken 3 doses and O2 level has increased to 99% and pulse was 62 bpm.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Tested positive for COVID-19; This spontaneous case was reported by an other health care professional and describes the occurrence of COVID-19 (Tested positive for COVID-19) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 25J20-2A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced COVID-19 (Tested positive for COVID-19). At the time of the report, COVID-19 (Tested positive for COVID-19) outcome was unknown.            Concomitant medications details was not reported by the reporter. Treatment details was not reported by the reporter.
11am on the 20th I noticed pain on my back torso and it came around to the left of my abdomen and was told it was textbook shingles rash and was prescribed valacyclovir 1gram 3x daily for one week, the pain is now mild and I can treat it with tylenol and I've only had to take it once, the rash is still there but it's not spreading I started the medication at 3pm after seeing the dr
Patient developed rash and fever 7 days after getting vaccinated. Fever running 99-102. Mild pink rash throughout body. Treatment Tylenol and Benadryl PRN
p/vax pt exp itching in the area of the lt arm;looked in mirror & discovered a reddened area;pt had scratched area once;pt @ hlth dept w/elongated area of redness & firmness;saw MD;induration;pain @ inject site & axilla;
This spontaneous report as received from a pharmacist refers to a 84 year old male patient with hypertension and chronic ischemic heart disease. On 08-OCT-2013 the patient was vaccinated with a dose of PNEUMOVAX 23 25/0.5 Y (lot # H014561, expiration date 21-MAR-2014, dose, route not reported in the left arm). Concomitant therapies included FLUZONE in the right arm on 08-OCT-2013. There was no drug reactions/allergies. On 08-OCT-2013, the patient experienced cellulitis of his left arm and later hospitalized in the intensive care unit. The patient sought medical attention via contacted pharmacist. The outcome of the event reported as recovering. Additional information has been requested.
nurse had given a pregnant women a fluzone HD shot by accident with no reported adverse event; Initial information received on 27-Jan-2022 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves Adult female patient who was exposed to vaccine INFLUENZA USP TRIVAL A-B VACCINE - UNSPECIFIED [FLUZONE UNSP] in context of nurse had given a pregnant women a fluzone hd shot by accident with no reported adverse event. Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known. The reported nurse had given a pregnant women a fluzone HD shot by accident with no reported adverse event occurred at unknown gestation period the gestation period at onset and gestation period at exposure data needs to be populated, if available.  The date of last menstrual period was not reported. The estimated due date was not reported. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. The patient had unknown previous pregnancy/ies.   On an unknown date, the patient received a  dose of suspect INFLUENZA USP TRIVAL A-B VACCINE - UNSPECIFIED lot number not reported via unknown route in unknown administration site for immunization.  On an unknown date the patient developed a non-serious event "nurse had given a pregnant women a fluzone hd shot by accident with no reported adverse event" (maternal exposure during pregnancy) (unknown latency) following the administration of INFLUENZA USP TRIVAL A-B VACCINE - UNSPECIFIED.  It was reported " I just spoke with a customer that stated her nurse had given a pregnant women a fluzone HD shot by accident. Patient is doing well and I told the clinic manager that you would follow up with her".  Action taken with INFLUENZA VACCINE TRIVALENT (FLUZONE UNSP) was not applicable.  At time of reporting, the outcome was Unknown for the event nurse had given a pregnant women a fluzone hd shot by accident with no reported adverse event. Additionally, at time of reporting, the outcome of the pregnancy is unknown.
1st dose 17Sep2021, 2nd 24Oct2022; This non-serious case was reported by a consumer via call center representative and described the occurrence of drug dose administration interval too long in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included shingrix (1st dose received on 17th September 2021, expiry date 25th January 2023 and LOT number C4NC5).   On 24-OCT-2022, the patient received the 2nd dose of Shingrix. On 24-OCT-2022, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too long (Verbatim: 1st dose 17Sep2021, 2nd 24Oct2022). The outcome of the drug dose administration interval too long was unknown.   Additional Information: GSK receipt date-27-MAR-2023 The patient received his/her Immunization record and it showed that a 2nd Shingrix vaccine was given on 24th October 2022. The patient did receive the vaccine (which was his/her first shot) but not the one on 17th September 2021. The reporter wanted to know could GlaxoSmithKline verify that the expiry date and lot number was even a Shingrix vaccine.
2/3/21: c/o  Fever, headache and vomiting; 2/3/21 at 7am:  Fever escalated; 2/4/21: Temp: 104; admitted to hospital; Dx: HSV-1,  Encephalitis; Tx: Acyclovir IV TID x 3 weeks, completes tx on 2/25/21   Admitted total of 6 days 2/10/21: discharged home, continues to have difficulty with computation of numbers and naming objects
This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE REACTION (Mild reaction that went away), VACCINATION SITE WARMTH (Site of the injection was hot), VACCINATION SITE PRURITUS (Site of the injection was is itchy), VACCINATION SITE SWELLING (Site of the injection was very swollen) and VACCINATION SITE ERYTHEMA (Site of the injection was red and hot) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Allergy to animal (Cats), Food allergy (many fruits), Pollen allergy, Hypertension since 1995 and Cholesterol since 1996. Concomitant products included LISINOPRIL for Cholesterol, SIMVASTATIN from 1995 to an unknown date for Hypertension. On 12-Jan-2021 at 8:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Site of the injection was hot), VACCINATION SITE PRURITUS (Site of the injection was is itchy), VACCINATION SITE SWELLING (Site of the injection was very swollen) and VACCINATION SITE ERYTHEMA (Site of the injection was red and hot). On 22-Jan-2021, the patient experienced FATIGUE (Fatigue). On an unknown date, the patient experienced VACCINATION SITE REACTION (Mild reaction that went away). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at a dose of UNK dosage form. On 25-Jan-2021, FATIGUE (Fatigue) had resolved. At the time of the report, VACCINATION SITE REACTION (Mild reaction that went away), VACCINATION SITE WARMTH (Site of the injection was hot), VACCINATION SITE PRURITUS (Site of the injection was is itchy), VACCINATION SITE SWELLING (Site of the injection was very swollen) and VACCINATION SITE ERYTHEMA (Site of the injection was red and hot) had resolved. Not Provided. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. This case was linked to MOD-2021-088993 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 14-Apr-2021: Follow up received on 14-PAR-2021 Contains patient demographic details updated, other  relevant history was updated, dosage information was updated, concomitant medications was updated, treatment information was updated, events was updated.
Pt complained of burning in the middle of her chest, pt was seen by Dr.  on site. Pt complained of acid reflux and hadn't eaten all. Was given juice and symptoms resolved and pt was released and advised of ED precautions.
Blurry vision post vaccination. My eyes sight also went from 20/20 now  suddenly cannot see clearly close.
The day after receiving my second dose of COVID-19 vaccine, my breastfed baby (4 mo) developed diarrhea.; The day after receiving my second dose of COVID-19 vaccine, my breastfed baby (4 mo) developed diarrhea.; This is a spontaneous report from a contactable consumer or other non hcp (patient's mother). This consumer or other non hcp reported information for both mother and baby. This is a baby report. A 04-month-old patient of unspecified gender was exposed to bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: unknown), via transmammary route, administered in Left arm on 17Aug2021 as dose 2, single for covid-19 immunisation from the mother. The patient's medical history was not reported. Concomitant medication included citalopram (CITALOPRAM) taken for an unspecified indication, start and stop date were not reported received within 2 weeks of vaccination. Facility where the most recent COVID-19 vaccine was administered was Pharmacy or Drug Store. Device Date : 20Aug2021. It was reported that the day after receiving her second dose of COVID-19 vaccine, her breastfed baby (4 mo) developed diarrhea on 18Aug2021. No treatment was received for adverse events. The reporter assessed events as non-serious with no seriousness criteria of resulting in death, Life threatening, Caused/prolonged hospitalization, Disabling/Incapacitating, Congenital anomaly/birth defect. Adverse events resulted in none of the above. The outcome of events was recovered on an unspecified date in 2021.  The lot number for the vaccine,[BNT162B2], was not provided and will be requested during follow up.
Approximately 12 hours after vaccine present with vertigo, that lasts for approximately 24-28 hrs. 5 days after vaccine started presenting with hives, self resolving, migratory. Some other common side effects already known were also present like chills, sore throat, headache, nauseas, tiredness, pain and induration at injection site.
About 3 hours after the vaccine, I started feeling a funny feeling in My throat. Like a tightness. I wasn?t having problems breathing . I was planning to call 911 if things got worse as I was home alone.  I had Benadryl at home so I took it. Within 10 minutes of taking it the symptoms went away. Also had some tingling and numbness in my left arm for 1-2 days .
After recovering from Covid (initially had a cough and it went away after about 7 days. About 2 weeks later, the cough returned and with a vengeance; This spontaneous case was reported by a patient and describes the occurrence of COUGH (After recovering from Covid (initially had a cough and it went away after about 7 days. About 2 weeks later, the cough returned and with a vengeance) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 005C21A) for COVID-19 vaccination.    Co-suspect product included non-company product NIRMATRELVIR, RITONAVIR (PAXLOVID) for COVID-19 prophylaxis.    Concurrent medical conditions included Hypothyroidism, Allergy to antibiotic (Amoxicillin), Drug allergy (Vicodin) and Fruit allergy (avocados).   On 29-Apr-2021 at 4:00 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2022, the patient started NIRMATRELVIR, RITONAVIR (PAXLOVID) (unknown route) at an unspecified dose. On 14-May-2022, the patient experienced COUGH (After recovering from Covid (initially had a cough and it went away after about 7 days. About 2 weeks later, the cough returned and with a vengeance). On 20-May-2022 at 2:00 PM, COUGH (After recovering from Covid (initially had a cough and it went away after about 7 days. About 2 weeks later, the cough returned and with a vengeance) had resolved with sequelae.    It was reported patient was not taking any medications/products within 2 weeks of starting COVID-19 treatment. Patient had received previously COVID-19 Vaccine. Device date was reported as 28May2022.